SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCI... ( SOURCE Senomyx Inc. ...)

(Date:11/24/2009)...ATTLE,Nov.24/PRNewswire-FirstCall/--CellTherapeuti...ntatthe21stAnnualPiperJaffrayHealthCareConference....rkPalaceHotel. ,, CTIwillpresentonTuesday,Decem...eaudiowebcastofCTI,spresentationwillbeavailableat ...forreplayafterwards. , ,PiperJaffrayHealthCareCon...

(Date:11/23/2009)...N, Ill. You can think of it as origami very high... Illinois have developed a technique for fabricati...tructures from thin films by coupling photolithogr...y interactions. , The films, only a few microns t...sible with thicker pieces of the same material. ,...

(Date:11/23/2009)... consists of a two-dimensional carbon layer in whi...ttice, resembling a honeycomb. Carbon nanotubes ar... graphene sheets form graphite. Graphene boasts so...ear-resistant, an excellent thermal conductor, and...ess and ductility. In addition, graphene is imperm...

(Date:11/23/2009)...SSISSAUGA,ON,Nov.23/PRNewswire-FirstCall/-YMBioSci...uctdevelopmentcompanythatidentifiesandadvancesadiv...riousstagesofdevelopment,todayreportedthatCytopia(...luatingCYT387,apotent,orally-administeredJAK1/JAK2...chester,Minnesota.AproposaltomergeCytopiaintoYMhas...

Breaking Biology Technology:Water droplets direct self-assembly process in thin-film materials 2 Polymer with honeycomb structure 2 YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2 YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3 YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4

[0] Cell Therapeutics, Inc. (CTI) to Present at 21st Annual Piper Jaffray Health Care Conference [0] Water droplets direct self-assembly process in thin-film materials [0] Polymer with honeycomb structure [0] YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA

...-dose cohorts plus data from subsequent higher-dos..., Calif., March 18 InterMune, Inc. (Nasdaq: ITM...ical study of ITMN-191 (R7227) in combination with...ferred to as the INFORM-1 study, has been accepted... at the 44th Annual Meeting of the European Associ...

.... Wright, Co-Chair of the Alliance for Biosecurity...ied today before the House Labor, Health and Human...ee on the critical importance of developing drugs,... to protect Americans from bioterrorism and other ... countermeasures for many of the chemical, biologi...

...Marin Pharmaceutical Inc. (Nasdaq: BMRN ) announ...authorization (CTA) for BMN 110 or N-acetylgalacto...ment of the lysosomal storage disorder Mucopolysac...me, has been accepted by the United Kingdom Medici...A). BioMarin expects to initiate a Phase 1/2 clini...

Other Biology Technology:INFORM-1 Interim Results Accepted for Late-Breaker Presentation at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL) 2 INFORM-1 Interim Results Accepted for Late-Breaker Presentation at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL) 3 INFORM-1 Interim Results Accepted for Late-Breaker Presentation at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL) 4 Alliance for Biosecurity Testifies Before Congress on Funding for Medical Countermeasure Development 2 BioMarin's Clinical Trial Application for GALNS for Morquio A Syndrome Accepted by the MHRA 2 BioMarin's Clinical Trial Application for GALNS for Morquio A Syndrome Accepted by the MHRA 3 BioMarin's Clinical Trial Application for GALNS for Morquio A Syndrome Accepted by the MHRA 4

INFORM-1 Interim Results Accepted for Late-Breaker Presentation at the 44th Annual Meeting of the European Association for the Study of the Liver (EASL)Alliance for Biosecurity Testifies Before Congress on Funding for Medical Countermeasure Development BioMarin's Clinical Trial Application for GALNS for Morquio A Syndrome Accepted by the MHRA

(Date:11/24/2009)...that may help gut bacteria bind to the gastrointes...c producers to identify strains that are likely to... to interact with cells lining the gut to have a b...n the gut they are more likely to stick around lon...e Juge from the Institute of Food Research. IFR i...

(Date:11/24/2009)...dical Toxicology (ACMT) have signed an agreement t...f Medical Toxicology (JMT), the official journal ...iously published by the University of Pennsylvania...an international, peer-reviewed journal, is dedica...al toxicology. The quarterly journal focuses on t...

(Date:11/24/2009)... of debate. A high-profile study a few years ago s...carbon from trees and leaves, evidence for a very ...systems. , But new research from the University ... Algae provide a much richer diet for fish and oth...his week in the Proceedings of the National Acade...

Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2 Springer and the American College of Medical Toxicology to work together 2 Fish food fight: Fish don't eat trees after all, says new study 2 Fish food fight: Fish don't eat trees after all, says new study 3 Minorities Less Likely to Have Blood Pressure Under Control 58190 1 Minorities Less Likely to Have Blood Pressure Under Control 58190 2 Minorities Less Likely to Have Blood Pressure Under Control 58190 3 The Hospital of Central Connecticut Selects Ingenious Med for Inpatient Practice Management 58185 1 The Hospital of Central Connecticut Selects Ingenious Med for Inpatient Practice Management 58185 2 The Hospital of Central Connecticut Selects Ingenious Med for Inpatient Practice Management 58185 3 Aviva Family and Childrens Services Hosts Rededication Ceremony of the Newly Renovated Wallis Annenberg Center 58180 1 Aviva Family and Childrens Services Hosts Rededication Ceremony of the Newly Renovated Wallis Annenberg Center 58180 2

[1] A sticky solution for identifying effective probiotics [1] Springer and the American College of Medical Toxicology to work together [0] Fish food fight: Fish don't eat trees after all, says new study

...ilian personnel from the U.S. Armed Forces, as wel...aw enforcement and other first-responder personnel...dia have been encouraged to register and attend th...PED VII). The event will be held at Stafford Regio...uring May 19-21. , , The demonstration, which is ...

..., University of Alabama at Birmingham professor of...Prize for Outstanding Innovation in Life Sciences....salutes Weaver,s achievements in advancing underst...ough T cell research. , According to Weaver, our...and cancer, but when T cells overreact and turn on...

...ng diverse forests for multiple uses is important ...dy conducted in southwestern Oregon provides fores...en managing land for a variety objectives that may...te level of wood production with some wildlife hab...s cover and forage for a wider variety of wildlife...

Other Biology News:Demonstration Features Commercial Technology for Combating Terrorism 2 UAB professor receives HudsonAlpha Innovation Prize 2 Managing Douglas-fir forests for diversity 2

Demonstration Features Commercial Technology for Combating Terrorism UAB professor receives HudsonAlpha Innovation Prize Managing Douglas-fir forests for diversity

PARP Cleavage Immunoblotting Assay Kit from Upstate

...o-Sequencing is designed to aid sequence analysis ...ning sites (MCS) of M13 phage vectors (mp18/19) or...). The kit is used to create nested unidirectional...y moving the primer binding site on the vector clo...

MaxArray Rat Brain Tissue Slides from Invitrogen

...ion Kit, 100 reactions. Prepare circular DNA templ...ram quantities of template DNA from picogram amoun... for cycle sequencing without purification.Amplify...es, plaques, or purified circular (plasmid or M13)...

Biology Products:

PARP Cleavage Immunoblotting Assay Kit from Upstate Kilo Sequencing Deletion Kit from Takara Mirus Bio MaxArray Rat Brain Tissue Slides from Invitrogen TempliPhi 100 Amplification Kit from GE Healthcare, formerly Amersham Biosciences

SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCI...( SOURCE Senomyx Inc. ...)